Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Identification of an Alternating-Access Dynamics Mutant of EmrE with Impaired Transport.

Wu C, Wynne SA, Thomas NE, Uhlemann EM, Tate CG, Henzler-Wildman KA.

J Mol Biol. 2019 May 31. pii: S0022-2836(19)30319-5. doi: 10.1016/j.jmb.2019.05.035. [Epub ahead of print]

2.

Localized Renal Masses: Comment on Recent American Urological Association Guideline.

Fatheree LA, Fitzgibbons PL, Rao P, Thomas NE, Zhou M, Tambouret R.

Arch Pathol Lab Med. 2019 Jun;143(6):659. doi: 10.5858/arpa.2019-0023-LE. No abstract available.

PMID:
31121111
3.

MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.

Pellegrini C, Botta F, Massi D, Martorelli C, Facchetti F, Gandini S, Maisonneuve P, Avril MF, Demenais F, Bressac-de Paillerets B, Hoiom V, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Marrett L, Zanetti R, Dwyer T, Thomas NE, Begg CB, Berwick M, Puig S, Potrony M, Nagore E, Ghiorzo P, Menin C, Manganoni AM, Rodolfo M, Brugnara S, Passoni E, Sekulovic LK, Baldini F, Guida G, Stratigos A, Ozdemir F, Ayala F, Fernandez-de-Misa R, Quaglino P, Ribas G, Romanini A, Migliano E, Stanganelli I, Kanetsky PA, Pizzichetta MA, García-Borrón JC, Nan H, Landi MT, Little J, Newton-Bishop J, Sera F, Fargnoli MC, Raimondi S; IMI Study Group; GEM Study Group; M-SKIP Study Group.

Lancet Child Adolesc Health. 2019 May;3(5):332-342. doi: 10.1016/S2352-4642(19)30005-7. Epub 2019 Mar 12.

PMID:
30872112
4.

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.

Zhao X, Little P, Hoyle AP, Pegna GJ, Hayward MC, Ivanova A, Parker JS, Marron DL, Soloway MG, Jo H, Salazar AH, Papakonstantinou MP, Bouchard DM, Jefferys SR, Hoadley KA, Ollila DW, Frank JS, Thomas NE, Googe PB, Ezzell AJ, Collichio FA, Lee CB, Earp HS, Sharpless NE, Hugo W, Wilmott JS, Quek C, Waddell N, Johansson PA, Thompson JF, Hayward NK, Mann GJ, Lo RS, Johnson DB, Scolyer RA, Hayes DN, Moschos SJ.

Front Oncol. 2019 Jan 4;8:584. doi: 10.3389/fonc.2018.00584. eCollection 2018.

5.

Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists.

Bui MM, Riben MW, Allison KH, Chlipala E, Colasacco C, Kahn AG, Lacchetti C, Madabhushi A, Pantanowitz L, Salama ME, Stewart RL, Thomas NE, Tomaszewski JE, Hammond ME.

Arch Pathol Lab Med. 2019 Jan 15. doi: 10.5858/arpa.2018-0378-CP. [Epub ahead of print]

PMID:
30645156
6.

Relationship of Chromosome Arm 10q Variants to Occurrence of Multiple Primary Melanoma in the Population-Based Genes, Environment, and Melanoma (GEM) Study.

Miles JA, Orlow I, Kanetsky PA, Luo L, Cust AE, Armstrong BK, Kricker A, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Gibbs DC, Busam KJ, Mavinkurve V, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

J Invest Dermatol. 2019 Jun;139(6):1410-1412. doi: 10.1016/j.jid.2018.11.030. Epub 2018 Dec 17. No abstract available.

PMID:
30571972
7.

Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.

Conway K, Edmiston SN, Parker JS, Kuan PF, Tsai YH, Groben PA, Zedek DC, Scott GA, Parrish EA, Hao H, Pearlstein MV, Frank JS, Carson CC, Wilkerson MD, Zhao X, Slater NA, Moschos SJ, Ollila DW, Thomas NE.

J Invest Dermatol. 2019 Jun;139(6):1349-1361. doi: 10.1016/j.jid.2018.11.024. Epub 2018 Dec 6.

PMID:
30529013
8.

The C terminus of the bacterial multidrug transporter EmrE couples drug binding to proton release.

Thomas NE, Wu C, Morrison EA, Robinson AE, Werner JP, Henzler-Wildman KA.

J Biol Chem. 2018 Dec 7;293(49):19137-19147. doi: 10.1074/jbc.RA118.005430. Epub 2018 Oct 4.

9.

Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis.

Thomas NE, Edmiston SN, Tsai YS, Parker JS, Googe PB, Busam KJ, Scott GA, Zedek DC, Parrish EA, Hao H, Slater NA, Pearlstein MV, Frank JS, Kuan PF, Ollila DW, Conway K.

Am J Dermatopathol. 2019 Apr;41(4):264-272. doi: 10.1097/DAD.0000000000001259.

PMID:
30211730
10.

A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.

Zhao Y, Schaafsma E, Gorlov IP, Hernando E, Thomas NE, Shen R, Turk MJ, Berwick M, Amos CI, Cheng C.

Mol Cancer Res. 2019 Jan;17(1):109-119. doi: 10.1158/1541-7786.MCR-18-0173. Epub 2018 Aug 31.

PMID:
30171176
11.

Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Thomas NE, Edmiston SN, Orlow I, Kanetsky PA, Luo L, Gibbs DC, Parrish EA, Hao H, Busam KJ, Armstrong BK, Kricker A, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group.

J Invest Dermatol. 2018 Nov;138(11):2398-2404. doi: 10.1016/j.jid.2018.04.025. Epub 2018 May 9.

12.

Surgical re-excision vs. observation for histologically dysplastic naevi: a systematic review of associated clinical outcomes.

Vuong KT, Walker J, Powell HB, Thomas NE, Jonas DE, Adamson AS.

Br J Dermatol. 2018 Sep;179(3):590-598. doi: 10.1111/bjd.16557. Epub 2018 Jun 21. Review.

PMID:
29570779
13.

Associations between metabolic syndrome components and markers of inflammation in Welsh school children.

Thomas NE, Rowe DA, Murtagh EM, Stephens JW, Williams R.

Eur J Pediatr. 2018 Mar;177(3):409-417. doi: 10.1007/s00431-017-3065-y. Epub 2017 Dec 22.

14.

Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists.

Lewis JS Jr, Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C, Moncur JT, Rocco JW, Schwartz MR, Seethala RR, Thomas NE, Westra WH, Faquin WC.

Arch Pathol Lab Med. 2018 May;142(5):559-597. doi: 10.5858/arpa.2017-0286-CP. Epub 2017 Dec 18.

PMID:
29251996
15.

New free-exchange model of EmrE transport.

Robinson AE, Thomas NE, Morrison EA, Balthazor BM, Henzler-Wildman KA.

Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10083-E10091. doi: 10.1073/pnas.1708671114. Epub 2017 Nov 7.

16.

The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.

Orlow I, Shi Y, Kanetsky PA, Thomas NE, Luo L, Corrales-Guerrero S, Cust AE, Sacchetto L, Zanetti R, Rosso S, Armstrong BK, Dwyer T, Venn A, Gallagher RP, Gruber SB, Marrett LD, Anton-Culver H, Busam K, Begg CB, Berwick M; GEM Study Group.

Pigment Cell Melanoma Res. 2018 Mar;31(2):287-296. doi: 10.1111/pcmr.12653. Epub 2017 Nov 5.

17.

Association of Delays in Surgery for Melanoma With Insurance Type.

Adamson AS, Zhou L, Baggett CD, Thomas NE, Meyer AM.

JAMA Dermatol. 2017 Nov 1;153(11):1106-1113. doi: 10.1001/jamadermatol.2017.3338.

18.

Tumor Mitotic Rate and Association with Recurrence in Sentinel Lymph Node Negative Stage II Melanoma Patients.

Laks S, Meyers MO, Deal AM, Frank JS, Stitzenberg KB, Yeh JJ, Thomas NE, Ollila DW.

Am Surg. 2017 Sep 1;83(9):972-978.

PMID:
28958277
19.

Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Thomas NE, Edmiston SN, Kanetsky PA, Busam KJ, Kricker A, Armstrong BK, Cust AE, Anton-Culver H, Gruber SB, Luo L, Orlow I, Reiner AS, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Parrish EA, Hao H, Gibbs DC, Frank JS, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group.

J Invest Dermatol. 2017 Dec;137(12):2588-2598. doi: 10.1016/j.jid.2017.07.832. Epub 2017 Aug 24.

20.

Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.

Vernali S, Waxweiler WT, Dillon PM, Kanetsky PA, Orlow I, Luo L, Busam KJ, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

JAMA Dermatol. 2017 Oct 1;153(10):1026-1031. doi: 10.1001/jamadermatol.2017.2444.

21.

Cash for carbon: A randomized trial of payments for ecosystem services to reduce deforestation.

Jayachandran S, de Laat J, Lambin EF, Stanton CY, Audy R, Thomas NE.

Science. 2017 Jul 21;357(6348):267-273. doi: 10.1126/science.aan0568.

PMID:
28729505
22.

Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.

Gibbs DC, Ward SV, Orlow I, Cadby G, Kanetsky PA, Luo L, Busam KJ, Kricker A, Armstrong BK, Cust AE, Anton-Culver H, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

Br J Dermatol. 2017 Nov;177(5):e180-e182. doi: 10.1111/bjd.15784. Epub 2017 Oct 6. No abstract available.

23.

Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma.

Mauguen A, Zabor EC, Thomas NE, Berwick M, Seshan VE, Begg CB.

J Am Stat Assoc. 2017;112(517):54-63. doi: 10.1080/01621459.2016.1191499. Epub 2017 May 3.

24.

A PGC1β genetic variant associated with nevus count and melanoma mortality.

Li X, Liu H, Amos CI, Lee JE, Thomas NE, Wei Q, Han J.

Int J Cancer. 2017 Sep 1;141(5):1066-1067. doi: 10.1002/ijc.30802. Epub 2017 Jun 8. No abstract available.

25.

Evaluation of Testing of Acute Leukemia Samples: Survey Result From the College of American Pathologists.

George TI, Tworek JA, Thomas NE, Fatheree LA, Souers RJ, Nakhleh RE, Arber DA.

Arch Pathol Lab Med. 2017 Aug;141(8):1101-1106. doi: 10.5858/arpa.2016-0398-CP. Epub 2017 May 24.

PMID:
28537804
26.

No association between prediagnosis exercise and survival in patients with high-risk primary melanoma: A population-based study.

Schwitzer E, Orlow I, Zabor EC, Begg CB, Berwick M, Thomas NE, Kanetsky PA, Jones LW; GEM Study Group.

Pigment Cell Melanoma Res. 2017 Jul;30(4):424-427. doi: 10.1111/pcmr.12594. Epub 2017 Jun 8. No abstract available.

27.

No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival.

Luo L, Orlow I, Kanetsky PA, Thomas NE, Fang S, Lee JE, Berwick M, Lee JH; GEM Study Group.

PLoS One. 2017 Mar 21;12(3):e0174234. doi: 10.1371/journal.pone.0174234. eCollection 2017.

28.

Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology.

Arber DA, Borowitz MJ, Cessna M, Etzell J, Foucar K, Hasserjian RP, Rizzo JD, Theil K, Wang SA, Smith AT, Rumble RB, Thomas NE, Vardiman JW.

Arch Pathol Lab Med. 2017 Oct;141(10):1342-1393. doi: 10.5858/arpa.2016-0504-CP. Epub 2017 Feb 22.

PMID:
28225303
29.

Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study.

White KA, Luo L, Thompson TA, Torres S, Hu CA, Thomas NE, Lilyquist J, Anton-Culver H, Gruber SB, From L, Busam KJ, Orlow I, Kanetsky PA, Marrett LD, Gallagher RP, Sacchetto L, Rosso S, Dwyer T, Cust AE, Begg CB, Berwick M; GEM Study Group.

Cancer Med. 2016 Nov;5(11):3336-3345. doi: 10.1002/cam4.929. Epub 2016 Oct 17.

30.

ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma.

Ryan MB, Finn AJ, Pedone KH, Thomas NE, Der CJ, Cox AD.

Mol Cancer Res. 2016 Oct;14(10):1009-1018. Epub 2016 Jul 14.

31.

An Empirical Analysis of Indoor Tanners: Implications for Audience Segmentation in Campaigns.

Kelley DE, Noar SM, Myrick JG, Morales-Pico B, Zeitany A, Thomas NE.

J Health Commun. 2016 May;21(5):564-74. doi: 10.1080/10810730.2015.1114051. Epub 2016 Apr 26.

PMID:
27115046
32.

Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.

Taylor NJ, Thomas NE, Anton-Culver H, Armstrong BK, Begg CB, Busam KJ, Cust AE, Dwyer T, From L, Gallagher RP, Gruber SB, Nishri DE, Orlow I, Rosso S, Venn AJ, Zanetti R, Berwick M, Kanetsky PA; GEM Study Group.

Int J Cancer. 2016 Sep 15;139(6):1217-22. doi: 10.1002/ijc.30157. Epub 2016 May 30.

33.

The state of melanoma: challenges and opportunities.

Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, Long GV, McArthur G, Ribas A, Schuchter L, Sosman JA, Smalley KS, Steeg P, Thomas NE, Tsao H, Tueting T, Weeraratna A, Xu G, Lomax R, Martin A, Silverstein S, Turnham T, Ronai ZA.

Pigment Cell Melanoma Res. 2016 Jul;29(4):404-16. doi: 10.1111/pcmr.12475. Epub 2016 Apr 17.

34.

Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center.

Sever C, Abbott CL, de Baca ME, Khoury JD, Perkins SL, Reichard KK, Taylor A, Terebelo HR, Colasacco C, Rumble RB, Thomas NE.

Arch Pathol Lab Med. 2016 Sep;140(9):932-49. doi: 10.5858/arpa.2015-0450-SA. Epub 2016 Feb 23.

PMID:
26905483
35.

Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Gibbs DC, Orlow I, Bramson JI, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

J Natl Cancer Inst. 2016 Feb 8;108(7). pii: djw004. doi: 10.1093/jnci/djw004. Print 2016 Jul.

36.

Melanoma Epidemiology and Prevention.

Berwick M, Buller DB, Cust A, Gallagher R, Lee TK, Meyskens F, Pandey S, Thomas NE, Veierød MB, Ward S.

Cancer Treat Res. 2016;167:17-49. doi: 10.1007/978-3-319-22539-5_2. Review.

PMID:
26601858
37.

Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.

Orlow I, Reiner AS, Thomas NE, Roy P, Kanetsky PA, Luo L, Paine S, Armstrong BK, Kricker A, Marrett LD, Rosso S, Zanetti R, Gruber SB, Anton-Culver H, Gallagher RP, Dwyer T, Busam K, Begg CB, Berwick M; GEM Study Group.

Carcinogenesis. 2016 Jan;37(1):30-8. doi: 10.1093/carcin/bgv157. Epub 2015 Oct 31.

38.

Effective intra-S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines.

Cordeiro-Stone M, McNulty JJ, Sproul CD, Chastain PD, Gibbs-Flournoy E, Zhou Y, Carson C, Rao S, Mitchell DL, Simpson DA, Thomas NE, Ibrahim JG, Kaufmann WK.

Pigment Cell Melanoma Res. 2016 Jan;29(1):68-80. doi: 10.1111/pcmr.12426. Epub 2015 Nov 3.

39.

A longitudinal test of the Comprehensive Indoor Tanning Expectations Scale: The importance of affective beliefs in predicting indoor tanning behavior.

Myrick JG, Noar SM, Kelley D, Zeitany AE, Morales-Pico BM, Thomas NE.

J Health Psychol. 2017 Jan;22(1):3-15. doi: 10.1177/1359105315595116. Epub 2016 Jul 10.

PMID:
26231616
40.

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

Thomas NE, Edmiston SN, Alexander A, Groben PA, Parrish E, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, From L, Busam KJ, Hao H, Orlow I, Kanetsky PA, Luo L, Reiner AS, Paine S, Frank JS, Bramson JI, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Cust AE, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group.

JAMA Oncol. 2015 Jun;1(3):359-68. Erratum in: JAMA Oncol. 2015 Jun;1(3):285.

41.

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.

Carson CC, Moschos SJ, Edmiston SN, Darr DB, Nikolaishvili-Feinberg N, Groben PA, Zhou X, Kuan PF, Pandey S, Chan KT, Jordan JL, Hao H, Frank JS, Hopkinson DA, Gibbs DC, Alldredge VD, Parrish E, Hanna SC, Berkowitz P, Rubenstein DS, Miller CR, Bear JE, Ollila DW, Sharpless NE, Conway K, Thomas NE.

Clin Cancer Res. 2015 May 1;21(9):2167-76. doi: 10.1158/1078-0432.CCR-14-1826.

42.

Uniform Labeling of Blocks and Slides in Surgical Pathology: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center and the National Society for Histotechnology.

Brown RW, Della Speranza V, Alvarez JO, Eisen RN, Frishberg DP, Rosai J, Santiago J, Tunnicliffe J, Colasacco C, Lacchetti C, Thomas NE.

Arch Pathol Lab Med. 2015 Dec;139(12):1515-24. doi: 10.5858/arpa.2014-0340-SA. Epub 2015 Apr 21.

PMID:
25897820
43.

Appearance normalization of histology slides.

Vicory J, Couture HD, Thomas NE, Borland D, Marron JS, Woosley J, Niethammer M.

Comput Med Imaging Graph. 2015 Jul;43:89-98. doi: 10.1016/j.compmedimag.2015.03.005. Epub 2015 Mar 21.

44.

Inherited genetic variants associated with occurrence of multiple primary melanoma.

Gibbs DC, Orlow I, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):992-7. doi: 10.1158/1055-9965.EPI-14-1426. Epub 2015 Apr 2.

45.

Inherited variation at MC1R and histological characteristics of primary melanoma.

Taylor NJ, Busam KJ, From L, Groben PA, Anton-Culver H, Cust AE, Begg CB, Dwyer T, Gallagher RP, Gruber SB, Orlow I, Rosso S, Thomas NE, Zanetti R, Rebbeck TR, Berwick M, Kanetsky PA.

PLoS One. 2015 Mar 19;10(3):e0119920. doi: 10.1371/journal.pone.0119920. eCollection 2015.

46.

Testing a social cognitive theory-based model of indoor tanning: implications for skin cancer prevention messages.

Noar SM, Myrick JG, Zeitany A, Kelley D, Morales-Pico B, Thomas NE.

Health Commun. 2015;30(2):164-74. doi: 10.1080/10410236.2014.974125.

PMID:
25470441
47.

Inherited variation at MC1R and ASIP and association with melanoma-specific survival.

Taylor NJ, Reiner AS, Begg CB, Cust AE, Busam KJ, Anton-Culver H, Dwyer T, From L, Gallagher RP, Gruber SB, Rosso S, White KA, Zanetti R, Orlow I, Thomas NE, Rebbeck TR, Berwick M, Kanetsky PA; GEM Study Group.

Int J Cancer. 2015 Jun 1;136(11):2659-67. doi: 10.1002/ijc.29317. Epub 2014 Nov 26.

48.

Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

Thomas NE, Kricker A, Waxweiler WT, Dillon PM, Busman KJ, From L, Groben PA, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Orlow I, Paine S, Ollila DW, Reiner AS, Luo L, Hao H, Frank JS, Begg CB, Berwick M; Genes, Environment, and Melanoma (GEM) Study Group.

JAMA Dermatol. 2014 Dec;150(12):1306-314.

49.

The origin of the local 1/4-keV X-ray flux in both charge exchange and a hot bubble.

Galeazzi M, Chiao M, Collier MR, Cravens T, Koutroumpa D, Kuntz KD, Lallement R, Lepri ST, McCammon D, Morgan K, Porter FS, Robertson IP, Snowden SL, Thomas NE, Uprety Y, Ursino E, Walsh BM.

Nature. 2014 Aug 14;512(7513):171-3. doi: 10.1038/nature13525. Epub 2014 Jul 27.

PMID:
25079321
50.

Sun exposure and melanoma survival: a GEM study.

Berwick M, Reiner AS, Paine S, Armstrong BK, Kricker A, Goumas C, Cust AE, Thomas NE, Groben PA, From L, Busam K, Orlow I, Marrett LD, Gallagher RP, Gruber SB, Anton-Culver H, Rosso S, Zanetti R, Kanetsky PA, Dwyer T, Venn A, Lee-Taylor J, Begg CB; GEM Study Group.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2145-52. doi: 10.1158/1055-9965.EPI-14-0431. Epub 2014 Jul 28.

Supplemental Content

Loading ...
Support Center